Skip to main content

Ballentine Partners, LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1374889 Waltham, MA

Position in RDY

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$1,557,370
+$104,672 QoQ
Shares Held
107,479
+2.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#68
of 238 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Ballentine Partners, LLC holds $5,578,380 across 9 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (27.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
This page
107,479 $1,557,370

All Filings in RDY

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,557,370 107,479
2026-03-31 $1,452,698 104,888
2025-12-31 $1,466,519 104,453
2025-09-30 $1,847,624 132,162
2025-06-30 $2,182,626 145,218
2025-03-31 $990,674 75,108
2024-12-31 $1,653,449 104,715
2024-09-30 $1,227,661 15,452
2024-06-30 $1,006,698 13,213
2024-03-31 $982,229 13,391
2023-12-31 $746,245 10,725
2023-09-30 $456,387 6,825
2023-06-30 $407,059 6,450